Earnings calls

Shree Ganesh Rem concall ledger

Every earnings call for 540737 — management tone, guidance, KPIs and promise tracking, quarter by quarter.

540737 · 3 transcripts · Healthcare · latest Q4 FY26

Shree Ganesh Rem has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

Q4 FY26Published 15 May 2026Call held 15 May 2026

540737 Q4 FY26 Earnings Call Transcript & Analysis

Revenue from Operations₹33.2 cr+36% YoYEBITDA₹11.37 cr+15% YoYEBITDA Margin34.3%PAT₹6.27 cr−5% YoY

Revenue from Operations ₹33 cr (+36% YoY); EBITDA ₹11 cr (+15% YoY); EBITDA Margin 34.3%. Revenue from operations grew 36% YoY to INR 33.20 crore in Q4 FY26.

Read full transcript & analysis

Q2 FY26Published 12 Nov 2025Call held 12 Nov 2025

540737 Q2 FY26 Earnings Call Transcript & Analysis

Q2 FY26 Revenue₹30.32 cr−6% YoYQ2 FY26 EBITDA₹9.62 crQ2 FY26 EBITDA Margin31.7%Q2 FY26 Net Profit₹4.93 cr−23% YoYH1 FY26 Revenue₹54.98 cr−4% YoY

Q2 FY26 Revenue ₹30 cr (−6% YoY); Q2 FY26 EBITDA ₹10 cr; Q2 FY26 EBITDA Margin 31.7%. Q2 FY26 Revenue: ₹30.32 crores, up 23% sequentially over Q1 FY26.

Read full transcript & analysis

Q4 FY25Published 21 May 2025Call held 21 May 2025

540737 Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹24.43 cr−35% YoYEBITDA₹9.88 cr−42% YoYEBITDA Margin40.4%PAT₹6.6 cr−48% YoY

Revenue (Q4 FY25) ₹24 cr (−35% YoY); EBITDA (Q4 FY25) ₹10 cr (−42% YoY); EBITDA Margin (Q4 FY25) 40.4%. Q4 FY25 Revenue from operations declined 35% YoY to ₹24.43 crores, primarily due to European slowdown and 25-30% lower realizations in domestic portfolio.

Read full transcript & analysis